🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Brachytherapy

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma NCT05894018Phase 21 site📍 Guangzhou Fujun Zhang · Tests: Fluzoparib, Radioactive particle implantation Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® NCT03290534Phase 21 site📍 New York CivaTech Oncology · Tests: CivaSheet Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). NCT07022470Phase 21 site📍 Palo Alto Stanford University · Tests: 3-Fraction HDR Brachytherapy, 4-Fraction HDR Brachytherapy SIRT Versus cTACE for Unresectable HCC (CHANCE2506) NCT06909708NA1 site📍 Nanjing Zhongda Hospital · Tests: SIRT, cTACE Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era NCT06508567NA1 site📍 Toronto University Health Network, Toronto · Tests: High Dose Rate Brachytherapy Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy NCT07204535n/a2 sites📍 Pierre-Bénite📍 Strasbourg Centre Paul Strauss · Tests: Prospective questionnaires Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease NCT03836196NA1 site📍 Vancouver British Columbia Cancer Agency · Tests: LDR Brachytherapy and External Beam Radiation Therapy Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors NCT05781555NA1 site📍 Jerusalem Alpha Tau Medical LTD. · Tests: Experimental: DaRT seeds Asian Gynecological Brachytherapy Registry in Cervical Cancer NCT07196033n/a5 sites📍 Mumbai📍 Maebashi📍 Tokyo Tata Memorial Hospital Salvage HDR for Locally Recurrent Prostate Cancer NCT04231006NA1 site📍 Aarhus Aarhus University Hospital · Tests: High dose rate brachytherapy Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer NCT07904182NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Absorbable Hydrogel Spacer Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma NCT06910306NA3 sites📍 Scottsdale📍 New York📍 Columbus Alpha Tau Medical LTD. · Tests: Device :DaRT seeds Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy NCT07435987NA1 site📍 Rotterdam Erasmus Medical Center · Tests: ARCHITECT applicator HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation NCT07786493NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: High-Dose-Rate Endorectal Brachytherapy Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies NCT05979610Phase 21 site📍 Salt Lake City University of Utah · Tests: Reiki therapy Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source NCT02843945Phase 1, Phase 26 sites📍 Tampa📍 Chicago📍 Oak Lawn CivaTech Oncology · Tests: Directional Brachytherapy Source Implant A Study Of Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer NCT07343531NA1 site📍 Cairo Ain Shams University · Tests: moderate hypofractionation external beam radiotherapy Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours NCT03238378NA1 site📍 Erlangen University of Erlangen-Nürnberg Medical School · Tests: Brachytherapy, Hyperthermia High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma NCT04945642NA1 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: High-Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy Quantifying Radiation Induced Vaginal Stenosis NCT05002751n/a1 site📍 La Jolla University of California, San Diego · Tests: UCSD Vaginal Dilator Questionnaire, EORTC Sexual Health Questionnaire Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC NCT05047094NA3 sites📍 Jerusalem📍 Ramat Gan📍 Tel Aviv Alpha Tau Medical LTD. · Tests: Diffusing Alpha Radiation Emitters Therapy (DaRT), Pembrolizumab TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT NCT05984511NA1 site📍 Guangzhou Third Affiliated Hospital, Sun Yat-Sen University · Tests: I-125 Seeds Brachytherapy in PVTT, Transcatheter arterial chemoembolization, Atezolizumab plus Bevacizumab Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC NCT06397222Phase 21 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Sin-Bev-SIRT ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy NCT06185205Phase 21 site📍 Richmond Virginia Commonwealth University · Tests: Accelerated partial breast irradiation Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer NCT07182279Phase 1, Phase 21 site📍 Houston The Methodist Hospital Research Institute · Tests: Brachytherapy Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer NCT05265208Phase 27 sites📍 Rennes📍 Pessac📍 Montpellier Center Eugene Marquis · Tests: Capecitabine, Selective Internal Radiotherapy (SIRT), Surgery Neoadjuvant Darovasertib in Primary Uveal Melanoma NCT07015190Phase 394 sites📍 Scottsdale📍 La Jolla📍 Los Angeles IDEAYA Biosciences · Tests: Darovasertib, Primary Local Therapy Retrospective Study of Brachytherapy NCT05242861n/a1 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Brachytherapy Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions NCT06284031NA1 site📍 Singapore National University Hospital, Singapore · Tests: 3 fractions HDR brachytherapy Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer NCT04831437Phase 21 site📍 Tehran Tehran University of Medical Sciences · Tests: Hypofractionated EBRT, Standard EBRT
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy